FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Curt Furberg

Research Profile

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Jean E Sealey; Michael H Alderman; Curt D Furberg; John H Laragh
Renin-Angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma Renin levels.
Suzanne Oparil; Jeffrey L Probstfield; Paul K Whelton; Jackson T Wright; William Cushman; Barry R Davis; Charles E Ford; Curt D Furberg; Gabriel B Habib; L Julian Haywood; Karen Margolis
Mortality and morbidity during and after antihypertensive and lipid-lowering treatment to prevent heart attack trial: results by sex.
Michael A Proschan; Michael H Alderman; Samuel S Blumenthal; Richard S Castaldo; William Cushman; Jeffrey A Cutler; Barry R Davis; Charles E Ford; Stanley S Franklin; Curt D Furberg; David Gordon; James F. Graumlich; Valory Pavlik; Richard A Preston
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Curt Furberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jean E Sealey; Michael H Alderman; Curt D Furberg; John H Laragh
Renin-Angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma Renin levels.
American journal of hypertension 2013;26(6):727-38.
2013: Suzanne Oparil; Jeffrey L Probstfield; Paul K Whelton; Jackson T Wright; William Cushman; Barry R Davis; Charles E Ford; Curt D Furberg; Gabriel B Habib; L Julian Haywood; Karen Margolis
Mortality and morbidity during and after antihypertensive and lipid-lowering treatment to prevent heart attack trial: results by sex.
Hypertension 2013;61(5):977-86.
2013: Michael A Proschan; Michael H Alderman; Samuel S Blumenthal; Richard S Castaldo; William Cushman; Jeffrey A Cutler; Barry R Davis; Charles E Ford; Stanley S Franklin; Curt D Furberg; David Gordon; James F. Graumlich; Valory Pavlik; Richard A Preston
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
Statistics in medicine 2013;32(5):884-97.
2013: Thomas J Moore; Curt D Furberg
Expedited review of new drugs--reply.
JAMA : the journal of the American Medical Association 2013;309(3):237.
2013: Sonal Singh; Yoon K Loke; Paul Enright; Curt D Furberg
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Thorax 2013;68(1):114-6.
2012: Allan D Sniderman; Curt D Furberg
Cardiovascular disease risk prediction factors.
JAMA : the journal of the American Medical Association 2012;308(19):1969; author reply 1970-1.
2012: Thomas J Moore; Curt D Furberg
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
JAMA : the journal of the American Medical Association 2012;308(9):869-70.
2012: Allan D Sniderman; George Thanassoulis; Ken Williams; Patrick R Lawler; Curt D Furberg
Comparison of coronary calcium screening versus broad statin therapy for patients at intermediate cardiovascular risk.
The American journal of cardiology 2012;110(4):530-3.
2012: David Madigan; James W Mayer; Daniel W Sigelman; Curt D Furberg; Jerry Avorn
Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies.
American heart journal 2012;164(2):186-93.
2012: Allan Sniderman; George Thanassoulis; Ken Williams; Ahsan Alam; Patrick Couture; Curt D Furberg
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein lowering.
Journal of clinical lipidology 2012;6(4):303-9.
2012: Allan D Sniderman; Curt D Furberg
Pluralism of viewpoints as the antidote to intellectual conflict of interest in guidelines.
Journal of clinical epidemiology 2012;65(7):705-7.
2012: Michael H Alderman; David A Calhoun; William Cushman; Barry R Davis; John H Eckfeldt; Paula T Einhorn; Charles E Ford; Stanley S Franklin; Curt D Furberg; Stephen T Ong; Suzanne Oparil; Vasilios Papademetriou; Linda B Piller; Jeffrey L Probstfield
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Hypertension 2012;59(5):926-33.
2012: frederick brancati; Mary Evans; Curt D Furberg; Nancy Geller; Steven Haffner; Steven E Kahn; Peter G Kaufmann; Cora E Lewis; David M Nathan; Bertram Pitt; Monika Maria Safford
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study.
Clinical trials (London, England) 2012;9(1):113-24.
2012: Richard Beasley; Paul Enright; Yoon K Loke; Sonal Singh; Curt D Furberg
Call for worldwide withdrawal of tiotropium Respimat mist inhaler.
BMJ (Clinical research ed.) 2012;345():e7390.
2012: Philip H Quanjer; Curt D Furberg
GOLD COPD stage I is not associated with increased risk of death.
Respiratory medicine 2012;106(1):153.
2011: Curt D Furberg
Understanding drug safety and how to maximize it for patients.
JAAPA : official journal of the American Academy of Physician Assistants 2011;24(11):16.
2011: Curt D Furberg
Renin test-guided drug treatment of hypertension: the need for clinical trials.
American journal of hypertension 2011;24(11):1158-63.
2011: Linda B Piller; Jeffrey L Probstfield; Tamrat M Retta; Mohammad G Saklayen; Lara M Simpson; Udho Thadani; Sarah Baraniuk; William Cushman; Aloysius B Cuyjet; Richard A Dart; Barry R Davis; Paula T Einhorn; Charles E Ford; Curt D Furberg; James F. Graumlich; Syed Z Jafri; Barrie Massie; Suzanne Oparil; David Parish
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
Circulation 2011;124(17):1811-8.
2011: Sonal Singh; John G Spangler; Yoon K Loke; Curt D Furberg
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2011;183(12):1359-66.
2011: Cassianne Robinson-Cohen; David S Siscovick; John A Robbins; Jane A Cauley; Zhao Chen; Ian H de Boer; Curt D Furberg; Andrew N Hoofnagle; Ronit Katz; Bryan Kestenbaum
Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study.
The Journal of clinical endocrinology and metabolism 2011;96(7):2186-93.
2011: Sonal Singh; Curt D Furberg
Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
Archives of internal medicine 2011;171(10):920-2.
2011: Allan D Sniderman; Ken Williams; John H Contois; Howard M Monroe; Matthew J McQueen; Jacqueline de Graaf; Curt D Furberg
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.
Circulation. Cardiovascular quality and outcomes 2011;4(3):337-45.
2011: Sonal Singh; Yoon K Loke; Curt D Furberg
Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis.
Thorax 2011;66(5):383-8.
2011: Thomas J Moore; Curt D Furberg; Joseph Glenmullen; John T Maltsberger; Sonal Singh
Suicidal behavior and depression in smoking cessation treatments.
PloS one 2011;6(11):e27016.
2011: Sonal Singh; Yoon K Loke; Paul L Enright; Curt D Furberg
Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials.
BMJ (Clinical research ed.) 2011;342():d3215.
2011: Elsayed Soliman; Shanthi Mendis; Wasantha P Dissanayake; Noel P Somasundaram; Padma S Gunaratne; I Kumudini Jayasingne; Curt D Furberg
A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health Organization.
Trials 2011;12():3.
2011: Anthony J Viera; Stacey L Sheridan; Teresa Edwards; Elsayed Z Soliman; Russell Harris; Curt D Furberg
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.
Preventive medicine 2011;52(1):10-5.
2010: Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James M Scheiman; Laurence S Sperling; Gordon F Tomaselli
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Circulation 2010;122(24):2619-33.
2010: Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James M Scheiman; Laurence S Sperling; Gordon F Tomaselli
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Journal of the American College of Cardiology 2010;56(24):2051-66.
2010: Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James M Scheiman; Laurence S Sperling; Gordon F Tomaselli
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
The American journal of gastroenterology 2010;105(12):2533-49.
2010: Sonal Singh; Curt D Furberg
Calcium supplements increase risk of myocardial infarction.
Evidence-based medicine 2010;15(6):181.
2010: Curt D Furberg
Renin-guided treatment of hypertension: time for action.
American journal of hypertension 2010;23(9):929-30.
2010: Thomas J Moore; Joseph Glenmullen; Curt D Furberg
Thoughts and acts of aggression/violence toward others reported in association with varenicline.
The Annals of pharmacotherapy 2010;44(9):1389-94.
2010: Randall S Stafford; L Kay Bartholomew; William C Cushman; Jeffrey A Cutler; Barry R Davis; Glenna Dawson; Paula T Einhorn; Curt D Furberg; Linda B Piller; Sara L Pressel; Paul K Whelton
Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use.
Archives of internal medicine 2010;170(10):851-8.
2010: Allan Sniderman; Matt McQueen; John Contois; Ken Williams; Curt D Furberg
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?
Journal of clinical lipidology 2010;4(3):152-5.
2010: Curt D Furberg
How should one analyse and interpret clinical trials in which patients don't take the treatments assigned to them?
Journal of the Royal Society of Medicine 2010;103(5):202-4.
2010: Tina E Brinkley; James Lovato; Alice M Arnold; Curt D Furberg; Lewis H Kuller; Gregory L Burke; Richard L Nahin; Oscar L Lopez; Sevil Yasar; Jeff D Williamson
Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women.
American journal of hypertension 2010;23(5):528-33.
2010: Nancy Swords Jenny; Cam Solomon; Mary Cushman; Russell P Tracy; Jeanenne J Nelson; Bruce M Psaty; Curt D Furberg
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study.
Atherosclerosis 2010;209(2):528-32.
2010: Allan D Sniderman; Ken Williams; Matthew J McQueen; Curt D Furberg
When is equal not equal?
Journal of clinical lipidology 2010;4(2):83-8.
2010: Thomas J Moore; Joseph Glenmullen; Curt D Furberg
Prescription drugs associated with reports of violence towards others.
PloS one 2010;5(12):e15337.
2010: Lewis H Kuller; Diane G Ives; Annette L Fitzpatrick; Michelle C Carlson; Carla Mercado; Oscar L Lopez; Gregory L Burke; Curt D Furberg; Steven T DeKosky
Does Ginkgo biloba reduce the risk of cardiovascular events?
Circulation. Cardiovascular quality and outcomes 2010;3(1):41-7.
2010: Inbal Boger-Megiddo; Susan R Heckbert; Noel S Weiss; Barbara McKnight; Curt D Furberg; Kerri L Wiggins; J A Chris Delaney; David S Siscovick; Eric B Larson; Rozenn N Lemaitre; Nicholas L Smith; Kenneth M Rice; Nicole L Glazer; Bruce M Psaty
Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study.
BMJ (Clinical research ed.) 2010;340():c103.
2009: Takeki Suzuki; Cam Solomon; Nancy Swords Jenny; Russell Tracy; Jeanenne J Nelson; Bruce M Psaty; Curt D Furberg; Mary Cushman
Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
Circulation. Heart failure 2009;2(5):429-36.
2009: J A Chris Delaney; Robyn L McClelland; Curt D Furberg; Richard Cooper; Steven Shea; Gregory Burke; Bruce M Psaty
Time trends in the use of anti-hypertensive medications: results from the Multi-Ethnic Study of Atherosclerosis.
Pharmacoepidemiology and drug safety 2009;18(9):826-32.
2009: Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas Altman; Sean R. Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;180(10):E47-57.
2009: Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas Altman; Sean R. Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
Journal of clinical epidemiology 2009;62(5):464-75.
2009: Curt D Furberg
[A clear winner and two losers].
Läkartidningen 2009;106(13):953.
2009: Curt D Furberg
[ACCOMPLISH and the risks with company sponsored clinical trials].
Läkartidningen 2009;106(7):450.
2009: Allan D Sniderman; Curt D Furberg
Why guideline-making requires reform.
JAMA : the journal of the American Medical Association 2009;301(4):429-31.
2009: Sonal Singh; Curt D Furberg; Yoon K Loke
Tiotropium in chronic obstructive pulmonary disease.
The New England journal of medicine 2009;360(2):186; author reply 187.
2009: Yoon K Loke; Sonal Singh; Curt D Furberg
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;180(1):32-9.
2009: Thomas J Moore; Curt D Furberg
Varenicline and suicide. Risk of psychiatric side effects with varenicline.
BMJ (Clinical research ed.) 2009;339():b4964.
2009: Curt D Furberg
Treatment of hypertension: a failing report card.
American journal of hypertension 2009;22(1):1-2.
2009: Sonal Singh; Curt D Furberg
Thiazolidinediones and cardiovascular outcomes in type 2 diabetes.
Heart (British Cardiac Society) 2009;95(1):1-3.
2008: Anita Kumar; Ronald J Prineas; Alice M Arnold; Bruce M Psaty; Curt D Furberg; John Robbins; Donald M Lloyd-Jones
Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study.
Circulation 2008;118(25):2790-6.
2008: Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Greg Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Ginkgo biloba for prevention of dementia: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;300(19):2253-62.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley; Robert A Harrington; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Mark A Hlatky; Sanjay Kaul; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Richard S Schofield; Robert S Rosenson; James H Stein; Howard H Weitz; Deborah J Wesley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
The American journal of gastroenterology 2008;103(11):2890-907.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley; Robert A Harrington; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Mark A Hlatky; Sanjay Kaul; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Richard S Schofield; Robert S Rosenson; James H Stein; Howard H Weitz; Deborah J Wesley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Journal of the American College of Cardiology 2008;52(18):1502-17.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Circulation 2008;118(18):1894-909.
2008: Sonal Singh; Yoon K Loke; Curt D Furberg
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
JAMA : the journal of the American Medical Association 2008;300(12):1439-50.
2008: Dariush Mozaffarian; Curt D Furberg; Bruce M Psaty; David Siscovick
Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study.
Circulation 2008;118(8):800-7.
2008: Nels Olson; Ellen S O'Meara; Nancy Swords Jenny; Aaron R Folsom; Edwin G Bovill; Curt D Furberg; Susan R Heckbert; Bruce M Psaty; Mary Cushman
Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults.
American journal of hematology 2008;83(7):524-7.
2008: Steven T DeKosky; Curt D Furberg
Turning over a new leaf: Ginkgo biloba in prevention of dementia?
Neurology 2008;70(19 Pt 2):1730-1.
2008: Allan D Sniderman; Curt D Furberg
Age as a modifiable risk factor for cardiovascular disease.
Lancet 2008;371(9623):1547-9.
2008: Curt D Furberg; Jeanenne J Nelson; Cam Solomon; Mary Cushman; Nancy Swords Jenny; Bruce M Psaty
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
Journal of the American Geriatrics Society 2008;56(5):792-9.
2008: Paul A Heidenreich; Barry R Davis; Jeffrey A Cutler; Curt D Furberg; David R Lairson; Michael G Shlipak; Sara L Pressel; Chuke Nwachuku; Lee Goldman
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Journal of general internal medicine 2008;23(5):509-16.
2008: John D Brunzell; Michael Davidson; Curt D Furberg; Ronald B Goldberg; Barbara V Howard; James H Stein; Joseph L Witztum
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
Journal of the American College of Cardiology 2008;51(15):1512-24.
2008: John D Brunzell; Michael Davidson; Curt D Furberg; Ronald B Goldberg; Barbara V Howard; James H Stein; Joseph L Witztum
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
Diabetes care 2008;31(4):811-22.
2008: Curt D Furberg; Elsayed Soliman
Double-blindness protects scientific validity.
Journal of thrombosis and haemostasis : JTH 2008;6(2):230-1.
2008: Jeff D Williamson; Bruno Vellas; Curt D Furberg; Richard L Nahin; Steven T DeKosky
Comparison of the design differences between the Ginkgo Evaluation of Memory study and the GuidAge study.
The journal of nutrition, health & aging 2008;12(1):73S-9S.
2007: Sonal Singh; Yoon K Loke; Curt D Furberg
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
JAMA : the journal of the American Medical Association 2007;298(10):1189-95.
2007: Thomas J Moore; Michael R Cohen; Curt D Furberg
Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
Archives of internal medicine 2007;167(16):1752-9.
2007: David P Miller; Curt D Furberg; Ronald H Small; Franklyn M Millman; Walter T Ambrosius; Julia S Harshbarger; Christopher A Ohl
Controlling prescription drug expenditures: a report of success.
The American journal of managed care 2007;13(8):473-80.
2007: Sonal Singh; Yoon K Loke; Curt D Furberg
Thiazolidinediones and heart failure: a teleo-analysis.
Diabetes care 2007;30(8):2148-53.
2007: Allan D Sniderman; Ingar Holme; Are H Aastveit; Curt D Furberg; Göran Walldius; Ingmar Jungner
Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.
The American journal of cardiology 2007;100(2):217-21.
2007: Bruce M Psaty; Curt D Furberg
The record on rosiglitazone and the risk of myocardial infarction.
The New England journal of medicine 2007;357(1):67-9.
2007: Bruce M Psaty; Curt D Furberg
Rosiglitazone and cardiovascular risk.
The New England journal of medicine 2007;356(24):2522-4.
2007: Elliott M Antman; Joel S Bennett; Alan Daugherty; Curt D Furberg; Harold Roberts; Kathryn A Taubert
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.
Circulation 2007;115(12):1634-42.
2007: C Ballantyne; M Cushman; B Psaty; Curt D Furberg; K T Khaw; M Sandhu; J Oldgren; G P Rossi; G Maiolino; M Cesari; L Lenzini; S K James; E Rimm; R Collins; J Anderson; W Koenig; H Brenner; D Rothenbacher; G Berglund; M Persson; P Berger; E Brilakis; J P McConnell; W Koenig; Ralph L Sacco; M Elkind; P Talmud; E Rimm; C P Cannon; C Packard; E Barrett-Connor; Albert Hofman; I Kardys; J C M Witteman; M Criqui; J P Corsetti; David L Rainwater; A J Moss; S Robins; H Bloomfield; D Collins; C Packard; Sylvia Wassertheil-Smoller; P Ridker; C Ballantyne; C P Cannon; M Cushman; J Danesh; D Gu; A Hofman; J J Nelson; S Thompson; A Zalewski; N Zariffa; E Di Angelantonio; S Kaptoge; A Thompson; S Thompson; M Walker; S Watson; A Wood
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(1):3-11.
2007: Kenneth J Mukamal; Bruce M Psaty; Pentti M Rautaharju; Curt D Furberg; Lewis H Kuller; Murray A Mittleman; John S Gottdiener; David S Siscovick
Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the Cardiovascular Health Study.
American heart journal 2007;153(2):260-6.
2007: Curt D Furberg
Decisions by regulatory agencies: are they evidence-based?
Trials 2007;8():13.
2006: Annette L Fitzpatrick; Linda P Fried; Jeff Williamson; Patricia Crowley; Delilah Posey; Linly Kwong; Janet Bonk; Roberta Moyer; Joyce Chabot; Lara Kidoguchi; Curt D Furberg; Steven T DeKosky
Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience.
Contemporary clinical trials 2006;27(6):541-53.
2006: Richard L Nahin; Annette L Fitzpatrick; Jeff D Williamson; Gregory L Burke; Steven T DeKosky; Curt D Furberg
Use of herbal medicine and other dietary supplements in community-dwelling older people: Baseline data from the ginkgo evaluation of memory study.
Journal of the American Geriatrics Society 2006;54(11):1725-35.
2006: Curt D Furberg; Arthur A Levin; Peter A Gross; Robyn S Shapiro; Brian L Strom
The FDA and drug safety: a proposal for sweeping changes.
Archives of internal medicine 2006;166(18):1938-42.
2006: Richard A Kronmal; Joshua I Barzilay; Nicholas L Smith; Bruce M Psaty; Lewis H Kuller; Gregory L Burke; Curt D Furberg
Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001.
PLoS medicine 2006;3(10):e400.
2006: Curt D Furberg
The COX-2 inhibitors--an update.
American heart journal 2006;152(2):197-9.
2006: Randall S Stafford; Veronica Monti; Curt D Furberg; Jun Ma
Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.
Hypertension 2006;48(2):213-8.
2006: Curt D Furberg
Adverse cardiovascular effects of rofecoxib.
The New England journal of medicine 2006;355(2):204; author reply 204-5.
2006: Robert D Furberg; Curt D Furberg
Evaluating professional performance in cardiovascular medicine.
Evidence-based cardiovascular medicine 2006;10(2):75-8.
2006: Steven T DeKosky; Annette Fitzpatrick; Diane G Ives; Judith Saxton; Jeff Williamson; Oscar L Lopez; Greg Burke; Linda P Fried; Lewis H Kuller; John Robbins; Russell Tracy; Nancy Woolard; Leslie Dunn; Richard A Kronmal; Richard L Nahin; Curt D Furberg
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.
Contemporary clinical trials 2006;27(3):238-53.
2006: Jane A Cauley; Anne McTiernan; Rebecca J Rodabough; Andrea LaCroix; Douglas Charles Bauer; Karen L Margolis; Electra D Paskett; Mara Z Vitolins; Curt D Furberg; Rowan T Chlebowski
Statin use and breast cancer: prospective results from the Women's Health Initiative.
Journal of the National Cancer Institute 2006;98(10):700-7.
2006: Barry R Davis; Linda B Piller; Jeffrey A Cutler; Curt D Furberg; Kay Dunn; Stanley Franklin; David Goff; Frans Leenen; Syed Mohiuddin; Vasilios Papademetriou; Michael A Proschan; Allan Ellsworth; John Golden; Pedro J Colon; Richard S Crow
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Circulation 2006;113(18):2201-10.
2006: Camille A Pearte; Curt D Furberg; Ellen S O'Meara; Bruce M Psaty; Lewis Kuller; Neil R Powe; Teri A Manolio
Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
Circulation 2006;113(18):2177-85.
2006: Bruce M Psaty; Noel S Weiss; Curt D Furberg
Recent trials in hypertension: compelling science or commercial speech?
JAMA : the journal of the American Medical Association 2006;295(14):1704-6.
2006: Ingmar Jungner; Allan D Sniderman; Curt D Furberg; Are H Aastveit; Ingar Holme; Göran Walldius
Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
The American journal of cardiology 2006;97(7):943-6.
2006: Philip J Barter; C M Ballantyne; R Carmena; Manuel Castro Cabezas; M John Chapman; P Couture; J de Graaf; P N Durrington; O Faergeman; J Frohlich; Curt D Furberg; C Gagne; Steven M Haffner; S E Humphries; Ingmar Jungner; R M Krauss; Peter O Kwiterovich; S Marcovina; C J Packard; Thomas A Pearson; K Srinath Reddy; Robert S Rosenson; Nizal Sarrafzadegan; Allan D Sniderman; A F Stalenhoef; E Stein; P J Talmud; A M Tonkin; Göran Walldius; K M S Williams
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Journal of internal medicine 2006;259(3):247-58.
2006: Paul L Canner; Curt D Furberg; Mark E McGovern
Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project).
The American journal of cardiology 2006;97(4):477-9.
2006: Pentti M Rautaharju; Sijian Ge; Jennifer C Nelson; Emily K Marino Larsen; Bruce M Psaty; Curt D Furberg; Zhu-ming Zhang; John Robbins; John S Gottdiener; Paulo H M Chaves
Comparison of mortality risk for electrocardiographic abnormalities in men and women with and without coronary heart disease (from the Cardiovascular Health Study).
The American journal of cardiology 2006;97(3):309-15.
2006: Douglas Altman; Curt D Furberg; Jeremy Grimshaw; Peter M Rothwell
Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials.
Trials 2006;7():6.
2006: Bruce M Psaty; Thomas Lumley; Curt D Furberg
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Kahn et al.
Diabetes care 2006;29(1):177; author reply 177-8.
2005: Marcello Tonelli; Anthony C Keech; Jim Shepherd; Frank M Sacks; Andrew Tonkin; Chris Packard; Marc Pfeffer; R John Simes; Chris Isles; Curt D Furberg; Malcolm West; Timothy Craven; Gary Curhan
Effect of pravastatin in people with diabetes and chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2005;16(12):3748-54.
2005: Gina D Schellenbaum; Nicholas L Smith; Susan R Heckbert; Thomas Lumley; Thomas D Rea; Curt D Furberg; Mary F Lyles; Bruce M Psaty
Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension.
Journal of the American Geriatrics Society 2005;53(11):1996-2000.
2005: John Butterworth; Lynne E Wagenknecht; Claudine Legault; Daniel J Zaccaro; Neal D Kon; John W Hammon; Anne T Rogers; B Todd Troost; David A Stump; Curt D Furberg; Laura H Coker
Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting.
The Journal of thoracic and cardiovascular surgery 2005;130(5):1319.
2005: Jeannie D Chan; Thomas D Rea; Nicholas L Smith; David S Siscovick; Susan R Heckbert; Thomas Lumley; Paulo H M Chaves; Curt D Furberg; Lewis Kuller; Bruce M Psaty
Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
American heart journal 2005;150(3):464-70.
2005: Marcello Tonelli; Chris Isles; Timothy Craven; Andrew Tonkin; Marc A Pfeffer; James Shepherd; Frank M Sacks; Curt D Furberg; Stuart M Cobbe; R John Simes; Malcolm West; Chris Packard; Gary C Curhan
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
Circulation 2005;112(2):171-8.
2005: Bruce M Psaty; Curt D Furberg
COX-2 inhibitors--lessons in drug safety.
The New England journal of medicine 2005;352(11):1133-5.
2005: Curt D Furberg; Bruce M Psaty; garret fitzgerald
Parecoxib, valdecoxib, and cardiovascular risk.
Circulation 2005;111(3):249.
2005: Paul L Canner; Curt D Furberg; Michael L Terrin; Mark E McGovern
Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).
The American journal of cardiology 2005;95(2):254-7.
2005: Curt D Furberg; Bruce M Psaty
Review: hormone replacement therapy may reduce the risk for death in younger but not older postmenopausal women.
ACP journal club 2005;142(1):1.
2005: William T Longstreth; Alice M Arnold; Norman J Beauchamp; Teri A Manolio; David Lefkowitz; Charles A Jungreis; Calvin Hirsch; Daniel H O'Leary; Curt D Furberg
Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.
Stroke; a journal of cerebral circulation 2005;36(1):56-61.
2004: Linda Fried; Cam Solomon; Michael G Shlipak; Stephen L Seliger; Catherine Stehman-Breen; Anthony J Bleyer; Paulo H M Chaves; Curt D Furberg; Lewis Kuller; Anne Newman
Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.
Journal of the American Society of Nephrology : JASN 2004;15(12):3184-91.
2004: Bruce M Psaty; Curt D Furberg; Wayne A Ray; Noel S Weiss
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis.
JAMA : the journal of the American Medical Association 2004;292(21):2622-31.
2004: Massimo Volpe; Michael H Alderman; Curt D Furberg; Rodney Jackson; John B Kostis; John H Laragh; Bruce M Psaty; Luis M Ruilope
Beyond hypertension toward guidelines for cardiovascular risk reduction.
American journal of hypertension 2004;17(11 Pt 1):1068-74.
2004: Chris L Bryson; Nicholas L Smith; Lewis H Kuller; Paulo H M Chaves; Teri A Manolio; William Lewis; Edward J Boyko; Curt D Furberg; Bruce M Psaty
Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists.
Journal of the American Geriatrics Society 2004;52(10):1648-54.
2004: Bruce M Psaty; Melissa Anderson; Richard A Kronmal; Russell P Tracy; Trevor Orchard; Linda P Fried; Thomas Lumley; John Robbins; Greg Burke; Anne B Newman; Curt D Furberg
The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study.
Journal of the American Geriatrics Society 2004;52(10):1639-47.
2004: Marcello Tonelli; Chris Isles; Gary C Curhan; Andrew Tonkin; Marc A Pfeffer; James Shepherd; Frank M Sacks; Curt D Furberg; Stuart M Cobbe; R John Simes; Timothy Craven; Malcolm West
Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Circulation 2004;110(12):1557-63.
2004: Bruce M Psaty; Curt D Furberg
Contemplating ACTION--long-acting nifedipine in stable angina.
Lancet 2004;364(9437):817-8.
2004: Bruce M Psaty; Thomas Lumley; Curt D Furberg
Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies.
JAMA : the journal of the American Medical Association 2004;292(1):43-4.
2004: Barry R Davis; Curt D Furberg; Jackson T Wright; Jeffrey A Cutler; Paul Whelton
ALLHAT: setting the record straight.
Annals of internal medicine 2004;141(1):39-46.
2004: Sumit R Majumdar; Finlay A McAlister; Curt D Furberg
From knowledge to practice in chronic cardiovascular disease: a long and winding road.
Journal of the American College of Cardiology 2004;43(10):1738-42.
2004: Caroline S Rhoads; Bruce M Psaty; Jean L Olson; Curt D Furberg
Medications and cardiovascular health in older adults: room for improvement in prevention and treatment.
The American journal of geriatric cardiology 2004;13(3):161-7.
2004: Randall S Stafford; Curt D Furberg; Stan N Finkelstein; Iain M Cockburn; Tseday Alehegn; Jun Ma
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
JAMA : the journal of the American Medical Association 2004;291(1):54-62.
2004: Göran Walldius; Ingmar Jungner; Are H Aastveit; Ingar Holme; Curt D Furberg; Allan D Sniderman
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(12):1355-63.
2004: Michael G Shlipak; Catherine Stehman-Breen; Eric Vittinghoff; Feng Lin; Paul D Varosy; Nanette K Wenger; Curt D Furberg
Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(1):37-44.
2004: Curt D Furberg; Bruce M Psaty
Carvedilol was more effective than metoprolol tartrate for lowering mortality in chronic heart failure.
ACP journal club 2004;140(1):5.
2003: Curt D Furberg
[Alfadil--positive documentation when it comes to safety is missing].
Läkartidningen 2003;100(51-52):4329; discussion 4330.
2003: Curt D Furberg
[Reduce prescription of expensive drugs without increased value].
Läkartidningen 2003;100(49):4113.
2003: Curt D Furberg; Bruce M Psaty
Should evidence-based proof of drug efficacy be extrapolated to a "class of agents"?
Circulation 2003;108(21):2608-10.
2003: Ashish K Jha; Paul D Varosy; Alka M Kanaya; Donald B Hunninghake; Mark A Hlatky; David D Waters; Curt D Furberg; Michael G Shlipak
Differences in medical care and disease outcomes among black and white women with heart disease.
Circulation 2003;108(9):1089-94.
2003: John Butterworth; Curt D Furberg
Improving cardiac outcomes after noncardiac surgery.
Anesthesia and analgesia 2003;97(3):613-5.
2003: Helmut Sinzinger; Harald Kritz; Curt D Furberg
Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(7):PI88-92.
2003: Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina D Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
JAMA : the journal of the American Medical Association 2003;289(19):2534-44.
2003: Allan D Sniderman; Curt D Furberg; A Keech; J E Roeters van Lennep; J Frohlich; Ingmar Jungner; Göran Walldius
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.
Lancet 2003;361(9359):777-80.
2003: Eric Vittinghoff; Michael G Shlipak; Paul D Varosy; Curt D Furberg; Christine C Ireland; Steven S Khan; Roger S Blumenthal; Elizabeth Barrett-Connor; Stephen B Hulley
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.
Annals of internal medicine 2003;138(2):81-9.
2003: Michael G Shlipak; Linda F Fried; Casey Crump; Anthony J Bleyer; Teri A Manolio; Russell P Tracy; Curt D Furberg; Bruce M Psaty
Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.
Circulation 2003;107(1):87-92.
2003: Ronald Klein; Barbara E K Klein; Emily K Marino; Lewis H Kuller; Curt D Furberg; Gregory L Burke; Larry D Hubbard
Early age-related maculopathy in the cardiovascular health study.
Ophthalmology 2003;110(1):25-33.
2002: Bruce M Psaty; Teri A Manolio; Nicholas L Smith; Susan R Heckbert; John S Gottdiener; Gregory L Burke; Joel Weissfeld; Paul L Enright; Thomas Lumley; Neil R Powe; Curt D Furberg
Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.
Archives of internal medicine 2002;162(20):2325-32.
2002: Gregory L Burke; Curt D Furberg
The evolution of public health sciences in an academic medical center.
Southern medical journal 2002;95(11):1248-53.
2002: John S Gottdiener; Robyn L McClelland; Robert Marshall; Lynn Shemanski; Curt D Furberg; Dalane W Kitzman; Mary Cushman; Joseph Polak; Julius M Gardin; Bernard J Gersh; Gerard P Aurigemma; Teri A Manolio
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study.
Annals of internal medicine 2002;137(8):631-9.
2002: Robert P Byington; Curt D Furberg; David M Herrington; J Alan Herd; Donald B Hunninghake; Maureen H Lowery; Ward A Riley; Timothy E Craven; Lily Chaput; Christine C Ireland; William B Applegate
Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(10):1692-7.
2002: Michael H Alderman; Curt D Furberg; John B Kostis; John H Laragh; Bruce M Psaty; Luis M Ruilope; Massimo Volpe; Rodney Jackson
Hypertension guidelines: criteria that might make them more clinically useful.
American journal of hypertension 2002;15(10 Pt 1):917-23.
2002: William T Longstreth; Corinne Dulberg; Teri A Manolio; Michael R Lewis; Norman J Beauchamp; Daniel O'Leary; John Carr; Curt D Furberg
Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.
Stroke; a journal of cerebral circulation 2002;33(10):2376-82.
2002: Barry R Davis; Jeffrey A Cutler; Curt D Furberg; Jackson T Wright; Michael A Farber; James V Felicetta; John D Stokes
Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.
Annals of internal medicine 2002;137(5 Part 1):313-20.
2002: Michael G Shlipak; Linda F Fried; Casey Crump; Anthony J Bleyer; Teri A Manolio; Russell P Tracy; Curt D Furberg; Bruce M Psaty
Cardiovascular disease risk status in elderly persons with renal insufficiency.
Kidney international 2002;62(3):997-1004.
2002: Stephen B Hulley; Curt D Furberg; Elizabeth Barrett-Connor; Jane A Cauley; Deborah Grady; William Haskell; Robert Knopp; Maureen H Lowery; Suzanne Satterfield; Helmut Schrott; Eric Vittinghoff; Donald B Hunninghake
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
JAMA : the journal of the American Medical Association 2002;288(1):58-66.
2002: Robert Kaplan; Susan R Heckbert; Curt D Furberg; Bruce M Psaty
Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction.
Journal of clinical epidemiology 2002;55(7):654-64.
2002: G B John Mancini; Michael E Miller; Gregory Evans; Robert P Byington; Curt D Furberg; Bertram Pitt
Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).
The American journal of cardiology 2002;89(12):1414-6.
2002: Curt D Furberg
Doxazosin, an inferior antihypertensive agent?
Journal of human hypertension 2002;16(6):375-7.
2002: Curt D Furberg
To whom do the research findings apply?
Heart (British Cardiac Society) 2002;87(6):570-4.
2002: Bruce M Psaty; Noel S Weiss; Curt D Furberg
The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
American journal of hypertension 2002;15(5):472-4.
2002: Robert Kaplan; Susan R Heckbert; Thomas D Koepsell; Frits R Rosendaal; Curt D Furberg; Lawton S Cooper; Bruce M Psaty
Calcium channel blocker use and gastrointestinal tract bleeding among older adults.
Age and ageing 2002;31(3):217-8.
2002: Frank M Sacks; Andrew M Tonkin; Timothy Craven; Marc A Pfeffer; James Shepherd; Anthony C Keech; Curt D Furberg; Eugene Braunwald
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
Circulation 2002;105(12):1424-8.
2002: Curt D Furberg; Eric Vittinghoff; Michael Davidson; David M Herrington; Joel A Simon; Nanette K Wenger; Stephen B Hulley
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned.
Circulation 2002;105(8):917-22.
2002: R John Simes; Curt D Furberg; E Braunwald; B R Davis; I Ford; Andrew Tonkin; J Shepherd
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
European heart journal 2002;23(3):207-15.
2002: S B Hulley; V Bittner; Curt D Furberg; Deborah Grady; David Herrington; E Vittinghoff; N Wenger
Hormone treatment--misconceptions and agreements.
European heart journal 2002;23(1):89-91.
2001: Curt D Furberg; Bruce M Psaty; M Pahor; Michael H Alderman
Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.
Annals of internal medicine 2001;135(12):1074-8.
2001: Annette L Fitzpatrick; Janet R Daling; Curt D Furberg; Richard A Kronmal; J L Weissfeld
Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.
Annals of epidemiology 2001;11(8):534-42.
2001: Luigi Ferrucci; Curt D Furberg; Brenda W J H Penninx; M DiBari; Jeff D Williamson; Jack M Guralnik; J G Chen; William B Applegate; Marco Pahor
Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.
Circulation 2001;104(16):1923-6.
2001: R Balkrishnan; Curt D Furberg
Developing an optimal approach to global drug safety.
Journal of internal medicine 2001;250(4):271-9.
2001: Michael G Shlipak; J A Simon; Deborah Grady; F Lin; Nanette K Wenger; Curt D Furberg
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease.
Journal of the American College of Cardiology 2001;38(3):705-11.
2001: Helmut Sinzinger; graziana lupattelli; Fahdi Chehne; Anthony Oguogho; Curt D Furberg
Isoprostane 8-epi-PGF2alpha is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy.
Journal of clinical pharmacy and therapeutics 2001;26(4):303-10.
2001: Susan R Heckbert; Robert Kaplan; Noel S Weiss; Bruce M Psaty; Danyu Lin; Curt D Furberg; Jacqueline R Starr; G D Anderson; Andrea Z LaCroix
Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy.
Archives of internal medicine 2001;161(14):1709-13.
2001: Pentti M Rautaharju; J C Nelson; R A Kronmal; Zhu-ming Zhang; John Robbins; John S Gottdiener; Curt D Furberg; Teri A Manolio; Linda P Fried
Usefulness of T-axis deviation as an independent risk indicator for incident cardiac events in older men and women free from coronary heart disease (the Cardiovascular Health Study).
The American journal of cardiology 2001;88(2):118-23.
2001: M Pahor; B M Psaty; Michael H Alderman; William B Applegate; Curt D Furberg
Blood-pressure-lowering treatment.
Lancet 2001;358(9276):152-3.
2001: B M Psaty; Curt D Furberg; L H Kuller; M Cushman; Peter J Savage; David M Levine; Daniel H O'Leary; R N Bryan; M Anderson; T Lumley
Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study.
Archives of internal medicine 2001;161(9):1183-92.
2001: Curt D Furberg; Bertram Pitt
Are all angiotensin-converting enzyme inhibitors interchangeable?
Journal of the American College of Cardiology 2001;37(5):1456-60.
2001: William T Longstreth; Charles Bernick; A Fitzpatrick; Mary Cushman; L Knepper; J Lima; Curt D Furberg
Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study.
Neurology 2001;56(3):368-75.
2001: Robert Kaplan; Susan R Heckbert; T D Koepsell; Curt D Furberg; J F Polak; R E Schoen; Bruce M Psaty
Risk factors for hospitalized gastrointestinal bleeding among older persons. Cardiovascular Health Study Investigators.
Journal of the American Geriatrics Society 2001;49(2):126-33.
2001: Stuart Pocock; Curt D Furberg
Procedures of data and safety monitoring committees.
American heart journal 2001;141(2):289-94.
2001: Sara Pressel; Barry R Davis; Jackson T Wright; Therese S Geraci; C Kingry; Charles E Ford; Linda B Piller; Judy Bettencourt; B Kimmel; Christine Lusk; H Parks; Lara M Simpson; Chuke Nwachuku; Curt D Furberg
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Controlled clinical trials 2001;22(1):29-41.
2001: Olaf Klungel; Susan R Heckbert; W T Longstreth; Curt D Furberg; Robert Kaplan; Nicholas L Smith; Rozenn N Lemaitre; Hubert G M Leufkens; A de Boer; Bruce M Psaty
Antihypertensive drug therapies and the risk of ischemic stroke.
Archives of internal medicine 2001;161(1):37-43.
2001: Larry B Goldstein; Robert J Adams; K Becker; Curt D Furberg; Philip B Gorelick; George Hademenos; Martha N Hill; George Howard; Virginia J Howard; B Jacobs; Steven R Levine; L Mosca; Ralph L Sacco; D G Sherman; Philip A Wolf; G J del Zoppo
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
Circulation 2001;103(1):163-82.
2001: Larry B Goldstein; Robert J Adams; K Becker; Curt D Furberg; Philip B Gorelick; George Hademenos; Martha N Hill; George Howard; Virginia J Howard; B Jacobs; Steven R Levine; L Mosca; Ralph L Sacco; D G Sherman; Philip A Wolf; G J del Zoppo
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
Stroke; a journal of cerebral circulation 2001;32(1):280-99.
2000: Marco Pahor; Bruce M Psaty; Michael H Alderman; William B Applegate; Jeff D Williamson; C Cavazzini; Curt D Furberg
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.
Lancet 2000;356(9246):1949-54.
2000: J R Crouse; Curt D Furberg
Treatment of dyslipidemia: room for improvement?
Arteriosclerosis, thrombosis, and vascular biology 2000;20(11):2333-5.
2000: Frank M Sacks; Andrew M Tonkin; J Shepherd; Eugene Braunwald; Stuart M Cobbe; C M Hawkins; Anthony C Keech; Chris Packard; R John Simes; Robert P Byington; Curt D Furberg
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project.
Circulation 2000;102(16):1893-900.
2000: A A Ariyo; M Haan; C M Tangen; John C Rutledge; M Cushman; Adrian S Dobs; Curt D Furberg
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group.
Circulation 2000;102(15):1773-9.
2000: B M Psaty; C Rhoads; Curt D Furberg
Evidence-based medicine: worship of form and treatment of high blood pressure.
Journal of general internal medicine 2000;15(10):755-6.
2000: Bertram Pitt; Robert P Byington; Curt D Furberg; Donald B Hunninghake; G B Mancini; Michael E Miller; Ward A Riley
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.
Circulation 2000;102(13):1503-10.
2000: B M Psaty; Curt D Furberg; M Pahor; Michael H Alderman; L H Kuller
National guidelines, clinical trials, and quality of evidence.
Archives of internal medicine 2000;160(17):2577-80.
2000: David M Herrington; David M Reboussin; K Bridget Brosnihan; Penny C Sharp; Sally A Shumaker; T E Snyder; Curt D Furberg; Glenn Kowalchuk; T D Stuckey; W J Rogers; D H Givens; David Waters
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
The New England journal of medicine 2000;343(8):522-9.
2000: Volker Knappertz; Charles H Tegeler; Curt D Furberg; DJ Wesley; Kathryn P Stewart; Dalane W Kitzman
Carotid Doppler high-intensity transient signals in dilated cardiomyopathy.
American heart journal 2000;140(2):E1-4.
2000: Marco Pahor; Bruce M Psaty; Michael H Alderman; William B Applegate; Jeff D Williamson; Curt D Furberg
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
Diabetes care 2000;23(7):888-92.
2000: Curt D Furberg
Class effects and evidence-based medicine.
Clinical cardiology 2000;23(7 Suppl 4):IV15-9.
2000: Deborah Grady; Nanette K Wenger; David Herrington; S Khan; Curt D Furberg; Donald B Hunninghake; Eric Vittinghoff; Stephen B Hulley
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Annals of internal medicine 2000;132(9):689-96.
2000: R Luoto; Teri A Manolio; E Meilahn; R Bhadelia; Curt D Furberg; L Cooper; Michael A Kraut
Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study.
Journal of the American Geriatrics Society 2000;48(5):467-72.
2000: M A Weber; Curt D Furberg
Comparisons in a competitive world: when is one drug superior to another?
American journal of hypertension 2000;13(4 Pt 1):457-9.
2000: Michael Miller; Robert P Byington; Donald B Hunninghake; Bertram Pitt; Curt D Furberg
Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators.
Archives of internal medicine 2000;160(3):343-7.
1999: H Sinzinger; M Rodrigues; Curt D Furberg
Dosing of atorvastatin and increases in fibrinogen level.
Atherosclerosis 1999;147(2):421-2.
1999: Curt D Furberg
Hypertension and diabetes: current issues.
American heart journal 1999;138(5 Pt 1):S400-5.
1999: Curt D Furberg; D M Herrington; Bruce M Psaty
Are drugs within a class interchangeable?
Lancet 1999;354(9185):1202-4.
1999: B M Psaty; Curt D Furberg
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity.
BMJ (Clinical research ed.) 1999;319(7210):589-90.
1999: D M Herrington; Curt D Furberg
Hormone therapy: time for replacement?
European heart journal 1999;20(18):1285-6.
1999: Bruce M Psaty; Noel S Weiss; Curt D Furberg; Thomas D Koepsell; David S Siscovick; Frits R Rosendaal; Nicholas L Smith; Susan R Heckbert; Robert Kaplan; Danyu Lin; Thomas R Fleming; EH Wagner
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.
JAMA : the journal of the American Medical Association 1999;282(8):786-90.
1999: Joshua I Barzilay; C F Spiekerman; PW Wahl; Lewis H Kuller; M Cushman; Curt D Furberg; Adrian S Dobs; Joseph F Polak; Peter J Savage
Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.
Lancet 1999;354(9179):622-5.
1999: Nicholas L Smith; Bruce M Psaty; Curt D Furberg; Richard H White; João A C Lima; Anne B Newman; Teri A Manolio
Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.
Archives of internal medicine 1999;159(14):1574-8.
1999: Robert P Byington; Gregory Evans; Mark A Espeland; William B Applegate; Donald B Hunninghake; Jeffrey L Probstfield; Curt D Furberg
Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Circulation 1999;100(3):e14-7.
1999: Bruce M Psaty; Curt D Furberg; Lewis H Kuller; Diane Bild; P M Rautaharju; Joseph F Polak; E Bovill; John S Gottdiener
Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study.
Archives of internal medicine 1999;159(12):1339-47.
1999: Bruce M Psaty; Thomas D Koepsell; Danyu Lin; N S Weiss; David S Siscovick; F R Rosendaal; M Pahor; Curt D Furberg
Assessment and control for confounding by indication in observational studies.
Journal of the American Geriatrics Society 1999;47(6):749-54.
1999: Richard H White; Mary Ann McBurnie; T Manolio; Curt D Furberg; J M Gardin; Steven Kittner; E Bovill; L Knepper
Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort.
The American journal of medicine 1999;106(2):165-71.
1999: Curt D Furberg
Natural statins and stroke risk.
Circulation 1999;99(2):185-8.
1998: M Pahor; Curt D Furberg
Calcium antagonists and cancer: causation or association?
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1998;12(6):511-3.
1998: Robert P Byington; Curt D Furberg; Timothy E Craven; Marco Pahor; James R Sowers
Isradipine in prediabetic hypertensive subjects.
Diabetes care 1998;21(12):2103-10.
1998: Rozenn N Lemaitre; Curt D Furberg; Anne B Newman; S B Hulley; D J Gordon; John S Gottdiener; R H McDonald; Bruce M Psaty
Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study.
Archives of internal medicine 1998;158(16):1761-8.
1998: Stephen B Hulley; Deborah Grady; T Bush; Curt D Furberg; David Herrington; B Riggs; Eric Vittinghoff
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
JAMA : the journal of the American Medical Association 1998;280(7):605-13.
1998: Marco Pahor; Curt D Furberg
Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.
Drugs & aging 1998;13(2):99-108.
1998: Deborah Grady; William B Applegate; Trudy L Bush; Curt D Furberg; B Riggs; Stephen B Hulley
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
Controlled clinical trials 1998;19(4):314-35.
1998: T J Moore; B M Psaty; Curt D Furberg
Time to act on drug safety.
JAMA : the journal of the American Medical Association 1998;279(19):1571-3.
1998: John R Crouse; Robert P Byington; Curt D Furberg
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data.
Atherosclerosis 1998;138(1):11-24.
1998: K A Pearce; Curt D Furberg; B M Psaty; J Kirk
Cost-minimization and the number needed to treat in uncomplicated hypertension.
American journal of hypertension 1998;11(5):618-29.
1998: Lawrence Gould; J E Rossouw; Nancy C Santanello; Joseph F Heyse; Curt D Furberg
Cholesterol reduction yields clinical benefit: impact of statin trials.
Circulation 1998;97(10):946-52.
1998: Marco Pahor; B M Psaty; Curt D Furberg
Treatment of hypertensive patients with diabetes.
Lancet 1998;351(9104):689-90.
1998: Curt D Furberg
Drug safety: the different perspectives.
Evidence-based cardiovascular medicine 1998;2(1):1-2.
1998: M Pahor; B M Psaty; Curt D Furberg
New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes.
Journal of cardiovascular pharmacology 1998;32 Suppl 2():S18-23.
1997: Susan R Heckbert; William T Longstreth; Bruce M Psaty; K E Murros; Nicholas L Smith; Anne B Newman; Jeff D Williamson; Charles Bernick; Curt D Furberg
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults.
Journal of the American Geriatrics Society 1997;45(12):1423-33.
1997: Curt D Furberg; B M Psaty
JNC VI: timing is everything.
Lancet 1997;350(9089):1413-4.
1997: B M Psaty; Curt D Furberg
Clinical implications of the World Health Organization-International Society of Hypertension statement on calcium antagonists.
Journal of hypertension 1997;15(11):1197-200.
1997: Robert P Byington; Michael E Miller; D Herrington; Ward A Riley; Bertram Pitt; Curt D Furberg; Donald B Hunninghake; G B Mancini
Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT).
The American journal of cardiology 1997;80(8):1087-90.
1997: Annette L Fitzpatrick; Janet R Daling; Curt D Furberg; Richard A Kronmal; J L Weissfeld
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Cancer 1997;80(8):1438-47.
1997: Robert P Byington; Timothy E Craven; Curt D Furberg; Marco Pahor
Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events.
Lancet 1997;350(9084):1075-6.
1997: Bruce M Psaty; Teri A Manolio; Lewis H Kuller; Richard A Kronmal; Mary Cushman; Linda P Fried; Richard H White; Curt D Furberg; P M Rautaharju
Incidence of and risk factors for atrial fibrillation in older adults.
Circulation 1997;96(7):2455-61.
1997: T A Manolio; Gail G Weinmann; A Sonia Buist; Curt D Furberg; J L Pinsky; S H Hurd
Pulmonary function testing in population-based studies.
American journal of respiratory and critical care medicine 1997;156(3 Pt 1):1004-10.
1997: Deborah Grady; Stephen B Hulley; Curt D Furberg
Venous thromboembolic events associated with hormone replacement therapy.
JAMA : the journal of the American Medical Association 1997;278(6):477.
1997: John R Crouse; Robert P Byington; H M Hoen; Curt D Furberg
Reductase inhibitor monotherapy and stroke prevention.
Archives of internal medicine 1997;157(12):1305-10.
1997: Curt D Furberg
School and home interventions improved children's dietary and physical activity behaviors.
Evidence-based cardiovascular medicine 1997;1(1):11.
1997: Burton E Sobel; Curt D Furberg
Surrogates, semantics, and sensible public policy.
Circulation 1997;95(6):1661-3.
1997: Bruce M Psaty; Nicholas L Smith; David S Siscovick; Thomas D Koepsell; Noel S Weiss; Susan R Heckbert; Rozenn N Lemaitre; E H Wagner; Curt D Furberg
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
JAMA : the journal of the American Medical Association 1997;277(9):739-45.
1997: M Pahor; B M Psaty; Curt D Furberg
More on calcium channel blockers in nephrology.
Journal of nephrology 1997;10(2):65; discussion 66-7.
1997: William B Applegate; Curt D Furberg; Robert P Byington; R Grimm
The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)
JAMA : the journal of the American Medical Association 1997;277(4):297; author reply 297-8.
1997: Michael A Proschan; B Davis; J Cutler; C Ford; Curt D Furberg; R Grimm; S Oparil
ALLHAT and calcium channel blockers. ALLHAT Research Group.
American journal of hypertension 1997;10(1):142-3.
1996: Curt D Furberg; B M Psaty
Should calcium antagonists be first-line agents in the treatment of cardiovascular disease? The public health perspective.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1996;10(4):463-6.
1996: T Ashraf; Joel W Hay; Bertram Pitt; E Wittels; J Crouse; M Davidson; Curt D Furberg; L Radican
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
The American journal of cardiology 1996;78(4):409-14.
1996: Curt D Furberg; M Pahor; B M Psaty
The unnecessary controversy.
European heart journal 1996;17(8):1142-7.
1996: P M Rautaharju; T A Manolio; D Siscovick; S H Zhou; J M Gardin; R Kronmal; Curt D Furberg; N O Borhani; A Newman
Utility of new electrocardiographic models for left ventricular mass in older adults. The Cardiovascular Health Study Collaborative Research Group.
Hypertension 1996;28(1):8-15.
1996: F R Rosendaal; B M Psaty; Curt D Furberg
[Calcium antagonists: safe or unsafe?].
Nederlands tijdschrift voor geneeskunde 1996;140(17):916-8.
1996: M Pahor; J M Guralnik; Curt D Furberg; Pierugo Carbonin; R Havlik
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.
Lancet 1996;347(9008):1061-5.
1996: Barry R Davis; J A Cutler; D J Gordon; Curt D Furberg; J T Wright; William Cushman; R H Grimm; J LaRosa; P K Whelton; H M Perry; Michael H Alderman; C E Ford; S Oparil; C Francis; M Proschan; S Pressel; H R Black; C M Hawkins
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.
American journal of hypertension 1996;9(4 Pt 1):342-60.
1996: Curt D Furberg; B M Psaty
Corrections to the nifedipine meta-analysis.
Circulation 1996;93(7):1475-6.
1996: Claudine Legault; Curt D Furberg; Lynne E Wagenknecht; A T Rogers; David A Stump; L Coker; B Todd Troost; John W Hammon
Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial.
Stroke; a journal of cerebral circulation 1996;27(4):593-8.
1996: Curt D Furberg; C H Hennekens; S B Hulley; T Manolio; B M Psaty; P K Whelton
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 2. Clinical epidemiology: the conceptual basis for interpreting risk factors.
Journal of the American College of Cardiology 1996;27(5):976-8.
1996: Robert P Byington; J W Jukema; J T Salonen; Bertram Pitt; A V Bruschke; H Hoen; Curt D Furberg; G B Mancini
[Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program].
Fortschritte der Medizin 1996;114(8):91-8.
1996: Mark A Espeland; Timothy E Craven; Ward A Riley; J Corson; A Romont; Curt D Furberg
Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group.
Stroke; a journal of cerebral circulation 1996;27(3):480-5.
1996: Bruce M Psaty; David S Siscovick; N S Weiss; T D Koepsell; F R Rosendaal; Danyu Lin; Susan R Heckbert; E H Wagner; Curt D Furberg
Hypertension and outcomes research. From clinical trials to clinical epidemiology.
American journal of hypertension 1996;9(2):178-83.
1996: Curt D Furberg; B M Psaty
Calcium antagonists: not appropriate as first line antihypertensive agents.
American journal of hypertension 1996;9(2):122-5.
1996: Daniel H O'Leary; Joseph F Polak; R A Kronmal; Peter J Savage; N O Borhani; Steven Kittner; Russell Tracy; J M Gardin; Thomas R Price; Curt D Furberg
Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group.
Stroke; a journal of cerebral circulation 1996;27(2):224-31.
1996: Ward A Riley; Timothy E Craven; A Romont; Curt D Furberg
Assessment of temporal bias in longitudinal measurements of carotid intimal-medial thickness in the Asymptomatic Carotid Artery Progression Study (ACAPS). ACAPS Research Group.
Ultrasound in medicine & biology 1996;22(4):405-11.
1995: Curt D Furberg; B M Psaty
Should calcium antagonists be first line drugs in hypertension?
Herz 1995;20(6):365-9.
1995: Mark A Espeland; William B Applegate; Curt D Furberg; D Lefkowitz; L Rice; Donald B Hunninghake
Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.
American journal of epidemiology 1995;142(10):1011-9.
1995: Curt D Furberg; B M Psaty
Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side.
Archives of internal medicine 1995;155(20):2157-61.
1995: Curt D Furberg; B M Psaty
Calcium antagonists: antagonists or protagonists of mortality in elderly hypertensives?
Journal of the American Geriatrics Society 1995;43(11):1309-10.
1995: Robert P Byington; J W Jukema; J T Salonen; Bertram Pitt; A V Bruschke; H Hoen; Curt D Furberg; G B Mancini
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program.
Circulation 1995;92(9):2419-25.
1995: K A Pearce; Curt D Furberg; J Rushing
Does antihypertensive treatment of the elderly prevent cardiovascular events or prolong life? A meta-analysis of hypertension treatment trials.
Archives of family medicine 1995;4(11):943-9; discussion 950.
1995: Curt D Furberg; Bertram Pitt; Robert P Byington; J S Park; M E McGovern
Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries.
The American journal of cardiology 1995;76(9):60C-63C.
1995: Robert P Byington; Curt D Furberg; John R Crouse; Mark A Espeland; M G Bond
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
The American journal of cardiology 1995;76(9):54C-59C.
1995: Jeffrey L Probstfield; S E Margitic; Robert P Byington; Mark A Espeland; Curt D Furberg
Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study.
The American journal of cardiology 1995;76(9):47C-53C.
1995: P M Rautaharju; Teri A Manolio; Curt D Furberg; D Siscovick; Anne B Newman; N O Borhani; J M Gardin
Ischemic episodes in 24-h ambulatory electrocardiograms of elderly persons: the Cardiovascular Health Study.
International journal of cardiology 1995;51(2):165-75.
1995: Curt D Furberg; B M Psaty; J V Meyer
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.
Circulation 1995;92(5):1326-31.
1995: Teri A Manolio; J A Cutler; Curt D Furberg; Bruce M Psaty; P K Whelton; William B Applegate
Trends in pharmacologic management of hypertension in the United States.
Archives of internal medicine 1995;155(8):829-37.
1995: Lawrence Gould; J E Rossouw; Nancy C Santanello; J F Heyse; Curt D Furberg
Cholesterol reduction yields clinical benefit. A new look at old data.
Circulation 1995;91(8):2274-82.
1995: S E Margitić; T M Morgan; Mark A Sager; Curt D Furberg
Lessons learned from a prospective meta-analysis.
Journal of the American Geriatrics Society 1995;43(4):435-9.
1995: Lynne E Wagenknecht; Curt D Furberg; John W Hammon; Claudine Legault; B Todd Troost
Surgical bleeding: unexpected effect of a calcium antagonist.
BMJ (Clinical research ed.) 1995;310(6982):776-7.
1995: John R Crouse; Robert P Byington; M G Bond; Mark A Espeland; Timothy E Craven; J W Sprinkle; M E McGovern; Curt D Furberg
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)
The American journal of cardiology 1995;75(7):455-9.
1995: R P Byington; Curt D Furberg
Reversing risk in coronary disease.
Lancet 1995;345(8945):330.
1995: P W Armstrong; Curt D Furberg
Clinical trial Data and Safety Monitoring Boards. The search for a constitution.
Circulation 1995;91(3):901-4.
1994: T Pearson; E Rapaport; M Criqui; Curt D Furberg; V Fuster; L Hiratzka; W Little; I Ockene; G Williams
Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group.
Circulation 1994;90(6):3125-33.
1994: Curt D Furberg
Lipid-lowering trials: results and limitations.
American heart journal 1994;128(6 Pt 2):1304-8.
1994: Göran Berglund; W A Riley; R W Barnes; Curt D Furberg
Quality control in ultrasound studies on atherosclerosis.
Journal of internal medicine 1994;236(5):581-6.
1994: Curt D Furberg; Robert P Byington; Timothy E Craven
Lessons learned from clinical trials with ultrasound end-points.
Journal of internal medicine 1994;236(5):575-80.
1994: Curt D Furberg; H P Adams; William B Applegate; Robert P Byington; Mark A Espeland; Tyler D Hartwell; Donald B Hunninghake; D S Lefkowitz; Jeffrey L Probstfield; Ward A Riley
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Circulation 1994;90(4):1679-87.
1994: Mark A Espeland; H Hoen; Robert P Byington; George Howard; Ward A Riley; Curt D Furberg
Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography.
Stroke; a journal of cerebral circulation 1994;25(9):1812-9.
1994: Curt D Furberg
Challenges to the funding of prevention research.
Preventive medicine 1994;23(5):599-601.
1994: Curt D Furberg; B M Psaty; T A Manolio; J M Gardin; V E Smith; P M Rautaharju
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).
The American journal of cardiology 1994;74(3):236-41.
1994: Lewis H Kuller; N Borhani; Curt D Furberg; J Gardin; T Manolio; D O'Leary; Bruce M Psaty; J Robbins
Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study.
American journal of epidemiology 1994;139(12):1164-79.
1994: Curt D Furberg; Robert P Byington; John R Crouse; Mark A Espeland
Pravastatin, lipids, and major coronary events.
The American journal of cardiology 1994;73(15):1133-4.
1994: P M Rautaharju; T A Manolio; B M Psaty; N O Borhani; Curt D Furberg
Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group.
The American journal of cardiology 1994;73(13):999-1002.
1994: Curt D Furberg; G Berglund; T A Manolio; B M Psaty
Overtreatment and undertreatment of hypertension.
Journal of internal medicine 1994;235(5):387-97.
1994: Teri A Manolio; Curt D Furberg; P M Rautaharju; David S Siscovick; Anne B Newman; N O Borhani; Julius M Gardin; BERNARD TABATZNIK
Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study.
Journal of the American College of Cardiology 1994;23(4):916-25.
1994: K A Pearce; Curt D Furberg
Hypertensive cardiovascular disease and the treatment of hypertension in the elderly.
Current opinion in nephrology and hypertension 1994;3(2):213-7.
1994: R Prentice; M Henderson; Curt D Furberg; L Kuller
Women's health and diet.
Nature 1994;367(6462):404.
1993: Teri A Manolio; Curt D Furberg; Lynn Shemanski; Bruce M Psaty; D H O'Leary; R P Tracy; Trudy L Bush
Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group.
Circulation 1993;88(5 Pt 1):2163-71.
1993: K K Teo; S Yusuf; Curt D Furberg
Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials.
JAMA : the journal of the American Medical Association 1993;270(13):1589-95.
1993: Curt D Furberg; R W Campbell; Bertram Pitt
ACE inhibitors after myocardial infarction.
The New England journal of medicine 1993;328(13):967-8; author reply 968-9.
1993: Curt D Furberg; N O Borhani; R P Byington; M E Gibbons; James R Sowers
Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
American journal of hypertension 1993;6(3 Pt 2):24S-29S.
1993: Curt D Furberg
Can we measure and predict atherosclerotic progression?
Circulation 1993;87(3 Suppl):II82.
1993: Jeffrey L Probstfield; Robert P Byington; DA Egan; Mark A Espeland; S E Margitic; Ward A Riley; Curt D Furberg
Methodological issues facing studies of atherosclerotic change.
Circulation 1993;87(3 Suppl):II74-81.
1993: S H Zhou; P M Rautaharju; R Prineas; J Neaton; R Crow; H Calhoun; Curt D Furberg; J Cohen
Improved ECG models for estimation of left ventricular hypertrophy progression and regression incidence by redefinition of the criteria for a significant change in left ventricular hypertrophy status. The MRFIT Research Group. Multiple Risk Factor Intervention Trial.
Journal of electrocardiology 1993;26 Suppl():108-13.
1992: John R Crouse; Robert P Byington; M G Bond; Mark A Espeland; J W Sprinkle; M McGovern; Curt D Furberg
Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.
Controlled clinical trials 1992;13(6):495-506.
1992: James L Wofford; A R Hickey; Walter H Ettinger; Curt D Furberg
Lack of age-related differences in the clinical presentation of digoxin toxicity.
Archives of internal medicine 1992;152(11):2261-4.
1992: Bruce M Psaty; Curt D Furberg; L H Kuller; N O Borhani; P M Rautaharju; Daniel H O'Leary; Diane Bild; J Robbins; Linda P Fried; C Reid
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study.
JAMA : the journal of the American Medical Association 1992;268(10):1287-91.
1992: Ward A Riley; R W Barnes; William B Applegate; R Dempsey; Tyler D Hartwell; V G Davis; M G Bond; Curt D Furberg
Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study.
Stroke; a journal of cerebral circulation 1992;23(8):1062-8.
1992: Astrid E Fletcher; Christopher J Bulpitt; D M Chase; W C Collins; Curt D Furberg; Timothy Goggin; A J Hewett; A M Neiss
Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.
Hypertension 1992;19(6 Pt 1):499-507.
1992: Curt D Furberg; Teri A Manolio; B M Psaty; Diane Bild; N O Borhani; A Newman; BERNARD TABATZNIK; P M Rautaharju
Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group.
The American journal of cardiology 1992;69(16):1329-35.
1992: T A Manolio; Curt D Furberg; P W Wahl; R P Tracy; N O Borhani; J M Gardin; Linda P Fried; D H O'Leary; Lewis H Kuller
Eligibility for cholesterol referral in community-dwelling older adults. The Cardiovascular Health Study.
Annals of internal medicine 1992;116(8):641-9.
1992: T A Manolio; Curt D Furberg
Age as a predictor of outcome: what role does it play?
The American journal of medicine 1992;92(1):1-6.
1991: S Yusuf; Curt D Furberg
Are we biased in our approach to treating elderly patients with heart disease?
The American journal of cardiology 1991;68(9):954-6.
1991: Curt D Furberg; S Yusuf
Antiarrhythmics and VPD suppression.
Circulation 1991;84(2):928-30.
1991: S Yusuf; P Held; Curt D Furberg
Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
The American journal of cardiology 1991;67(15):1295-7.
1991: N O Borhani; William B Applegate; J A Cutler; Barry R Davis; Curt D Furberg; E Lakatos; L Page; H M Perry; W M Smith; J L Probstfield
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design.
Hypertension 1991;17(3 Suppl):II2-15.
1991: S E Margitić; M G Bond; John R Crouse; Curt D Furberg; Jeffrey L Probstfield
Progression and regression of carotid atherosclerosis in clinical trials.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(2):443-51.
1991: A R Hickey; T L Wenger; V P Carpenter; H H Tilson; M A Hlatky; Curt D Furberg; C H Kirkpatrick; H C Strauss; T W Smith
Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.
Journal of the American College of Cardiology 1991;17(3):590-8.
1991: Linda P Fried; N O Borhani; P Enright; Curt D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; maurice mittelmark; A Newman
The Cardiovascular Health Study: design and rationale.
Annals of epidemiology 1991;1(3):263-76.
1991: Curt D Furberg
Organizing multicenter trials: lessons from cardiovascular prevention trials.
Preventive medicine 1991;20(1):158-61.
1990: Robert P Byington; J Worthy; Timothy E Craven; Curt D Furberg
Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience.
The American journal of cardiology 1990;65(20):1287-91.
1990: S Rössner; C L Taylor; R P Byington; Curt D Furberg
Long term propranolol treatment and changes in body weight after myocardial infarction.
BMJ (Clinical research ed.) 1990;300(6729):902-3.
1990: R A Kronmal; G H Rutan; N O Borhani; T A Manolio; Curt D Furberg
Potential problems with random zero sphygmomanometer.
Lancet 1990;335(8685):360.
1990: J L Probstfield; Curt D Furberg
Systolic hypertension in the elderly: controlled or uncontrolled.
Cardiovascular clinics 1990;20(3):65-84.
1989: P H Held; S Yusuf; Curt D Furberg
Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.
BMJ (Clinical research ed.) 1989;299(6709):1187-92.
1989: R I Levy; D Blankenhorn; C E Davis; D J Gordon; Curt D Furberg; J Huttunen; R J Levine; E Passamani; S Yusuf
AHA Conference Report on Cholesterol. Intervention studies.
Circulation 1989;80(3):739-43.
1989: Curt D Furberg
The impact of clinical trials on clinical practice.
Arzneimittel-Forschung 1989;39(8A):986-8.
1989: B A Brody; A R Feinstein; Curt D Furberg; W Siegenthaler; I Urquhart; T R Weihrauch
Panel discussion. I: Cost effectiveness of drug development and health economics.
Arzneimittel-Forschung 1989;39(8A):989-95.
1989: Curt D Furberg; J A Cutler
Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.
Hypertension 1989;13(5 Suppl):I57-61.
1989: J A Cutler; S W MacMahon; Curt D Furberg
Controlled clinical trials of drug treatment for hypertension. A review.
Hypertension 1989;13(5 Suppl):I36-44.
1989: Curt D Furberg; J A Cutler
The National Heart, Lung, and Blood Institute Workshop on antihypertensive drug treatment. The benefits, costs, and choices. Implications for research.
Hypertension 1989;13(5 Suppl):I171-2.
1989: Curt D Furberg; R P Byington; N A Borhani
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.
The American journal of medicine 1989;86(4A):37-9.
1989: Donald S Prough; Curt D Furberg
Nimodipine and the "no-reflow phenomenon"--experimental triumph, clinical failure?
Anesthesia and analgesia 1989;68(4):431-5.
1989: H M Perry; W M Smith; R H McDonald; D Black; J A Cutler; Curt D Furberg; M R Greenlick; L H Kuller; H W Schnaper; J A Schoenberger
Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.
Stroke; a journal of cerebral circulation 1989;20(1):4-13.
1989: Jeffrey L Probstfield; William B Applegate; N O Borhani; J David Curb; J A Cutler; Barry R Davis; Curt D Furberg; C M Hawkins; E Lakatos; L B Page
The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11(5-6):973-89.
1989: Curt D Furberg; R P Byington
Beta-adrenergic blockers in patients with acute myocardial infarction.
Cardiovascular clinics 1989;20(1):235-48.
1988: Curt D Furberg; S Yusuf
Effect of drug therapy on survival in chronic congestive heart failure.
The American journal of cardiology 1988;62(2):41A-45A.
1988: Curt D Furberg
A randomized study of 5-fluorouracil and filtration surgery.
American journal of ophthalmology 1988;105(4):434-5.
1988: N K Wenger; Curt D Furberg; E Pitt
Coronary heart disease in the elderly: review of current knowledge and research recommendations.
Clinical cardiology 1988;11(4):262-4.
1988: G S Tell; John R Crouse; Curt D Furberg
Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A review.
Stroke; a journal of cerebral circulation 1988;19(4):423-30.
1988: Curt D Furberg
The secondary prevention trials. Lessons learned, questions raised.
Postgraduate medicine 1988;Spec No():83-9.
1988: Curt D Furberg; D M Black
The systolic hypertension in the elderly pilot program: methodological issues.
European heart journal 1988;9(2):223-7.
1988: Curt D Furberg
Secondary prevention trials after myocardial infarction.
Journal of cardiovascular pharmacology 1988;12 Suppl 1():S83-7.
1987: S Yusuf; Curt D Furberg
Effects of calcium channel blockers on survival after myocardial infarction.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1987;1(4):343-4.
1987: John B Kostis; R Byington; L M Friedman; S Goldstein; Curt D Furberg
Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction.
Journal of the American College of Cardiology 1987;10(2):231-42.
1987: Curt D Furberg
Secondary prevention trials after acute myocardial infarction.
The American journal of cardiology 1987;60(2):28A-32A.
1987: A P Shapiro; Michael H Alderman; T B Clarkson; Curt D Furberg; M J Jesse; Stevo Julius; R E Miller; Bertram Pitt
Behavioral consequences of hypertension and antihypertensive therapy.
Circulation 1987;76(1 Pt 2):I101-3.
1987: J E Dimsdale; W Ruberman; R A Carleton; V DeQuattro; E Eaker; R S Eliot; Curt D Furberg; C W Irvin; B Lown; A P Shapiro
Sudden cardiac death. Stress and cardiac arrhythmias.
Circulation 1987;76(1 Pt 2):I198-201.
1987: P T Costa; D S Krantz; J A Blumenthal; Curt D Furberg; R H Rosenman; R B Shekelle
Psychological risk factors in coronary artery disease.
Circulation 1987;76(1 Pt 2):I145-9.
1987: B R Davis; Curt D Furberg; C B Williams
Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial.
Clinical pharmacology and therapeutics 1987;41(6):611-5.
1987: Curt D Furberg; T M Morgan
Lessons from overviews of cardiovascular trials.
Statistics in medicine 1987;6(3):295-306.
1987: Curt D Furberg
Overview of completed sudden death trials: US experience.
Cardiology 1987;74 Suppl 2():24-31.
1986: H M Perry; R H McDonald; S B Hulley; W M Smith; Curt D Furberg; M R Greenlick; L H Kuller; H W Schnaper; J A Schoenberger; Thomas M. Vogt
Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): morbidity and mortality experience.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1986;4(6):S21-3.
1986: S W MacMahon; J A Cutler; J D Neaton; Curt D Furberg; J D Cohen; L H Kuller; J Stamler
Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1986;4(6):S14-7.
1986: S W MacMahon; J A Cutler; Curt D Furberg; G H Payne
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials.
Progress in cardiovascular diseases 1986;29(3 Suppl 1):99-118.
1986: P M Rautaharju; S K Broste; R J Prineas; W J Eifler; R S Crow; Curt D Furberg
Quality control procedures for the resting electrocardiogram in the Multiple Risk Factor Intervention Trial.
Controlled clinical trials 1986;7(3 Suppl):46S-65S.
1986: P M Rautaharju; R J Prineas; W J Eifler; Curt D Furberg; J D Neaton; R S Crow; J Stamler; J A Cutler
Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience.
Journal of the American College of Cardiology 1986;8(1):1-10.
1986: R S Crow; P M Rautaharju; R J Prineas; J E Connett; Curt D Furberg; S Broste; J Stamler
Risk factors, exercise fitness and electrocardiographic response to exercise in 12,866 men at high risk of symptomatic coronary heart disease.
The American journal of cardiology 1986;57(13):1075-82.
1986: W M Smith; D W Feigal; Curt D Furberg; M Greenlick; L Kuller; H M Perry; H W Schnaper; J A Schoenberger
Use of diuretics in treatment of hypertension in the elderly.
Drugs 1986;31 Suppl 4():154-64.
1986: Curt D Furberg; S Yusuf
Effect of drug therapy on survival in chronic heart failure.
Advances in cardiology 1986;34():124-30.
1986: L M Friedman; R P Byington; R J Capone; Curt D Furberg; Sidney Goldstein; E Lichstein
Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia.
Journal of the American College of Cardiology 1986;7(1):1-8.
1986: S Yusuf; J Wittes; K Bailey; Curt D Furberg
Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methods.
Circulation 1986;73(1):14-8.
1985: S B Hulley; Curt D Furberg; B Gurland; R McDonald; H M Perry; H W Schnaper; J A Schoenberger; W M Smith; Thomas M. Vogt
Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone.
The American journal of cardiology 1985;56(15):913-20.
1985: W H Frishman; J Ruggio; Curt D Furberg
Use of beta-adrenergic blocking agents after myocardial infarction.
Postgraduate medicine 1985;78(8):40-6, 49-53.
1985: Thomas Walle; R P Byington; Curt D Furberg; K M McIntyre; P S Vokonas
Biologic determinants of propranolol disposition: results from 1308 patients in the Beta-Blocker Heart Attack Trial.
Clinical pharmacology and therapeutics 1985;38(5):509-18.
1985: J A Cutler; Curt D Furberg
Drug treatment trials in hypertension: a review.
Preventive medicine 1985;14(4):499-518.
1985: S Yusuf; R Collins; R Peto; Curt D Furberg; M J Stampfer; S Z Goldhaber; C H Hennekens
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.
European heart journal 1985;6(7):556-85.
1985: Curt D Furberg; S Yusuf
Effect of vasodilators on survival in chronic congestive heart failure.
The American journal of cardiology 1985;55(8):1110-3.
1985: Curt D Furberg; S Yusuf; T J Thom
Potential for altering the natural history of congestive heart failure: need for large clinical trials.
The American journal of cardiology 1985;55(2):45A-47A.
1985: Curt D Furberg
The Beta-blocker Heart Attack Trial.
Zeitschrift für Kardiologie 1985;74 Suppl 6():159-63.
1985: W H Frishman; L I Laifer; Curt D Furberg
Beta-adrenergic blockers in the prevention of sudden death.
Cardiovascular clinics 1985;15(3):249-64.
1984: N K Wenger; M E Mattson; Curt D Furberg; J Elinson
Assessment of quality of life in clinical trials of cardiovascular therapies.
The American journal of cardiology 1984;54(7):908-13.
1984: Curt D Furberg; G S May
Effect of long-term prophylactic treatment on survival after myocardial infarction.
The American journal of medicine 1984;76(6A):76-83.
1984: W H Frishman; Curt D Furberg; W T Friedewald
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Current problems in cardiology 1984;9(3):1-50.
1984: Curt D Furberg; C M Hawkins; E Lichstein
Effect of propranolol in postinfarction patients with mechanical or electrical complications.
Circulation 1984;69(4):761-5.
1984: W H Frishman; Curt D Furberg; W T Friedewald
Beta-adrenergic blockade for survivors of acute myocardial infarction.
The New England journal of medicine 1984;310(13):830-7.
1984: Curt D Furberg
Clinical value of intracoronary streptokinase.
The American journal of cardiology 1984;53(4):626-7.
1983: Curt D Furberg
Effect of antiarrhythmic drugs on mortality after myocardial infarction.
The American journal of cardiology 1983;52(6):32C-36C.
1983: Curt D Furberg; R P Byington
What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
Circulation 1983;67(6 Pt 2):I98-101.
1983: Curt D Furberg; R L Bell
Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
Circulation 1983;67(6 Pt 2):I83-5.
1983: G S May; Curt D Furberg; K A Eberlein; B J Geraci
Secondary prevention after myocardial infarction: a review of short-term acute phase trials.
Progress in cardiovascular diseases 1983;25(4):335-59.
1982: L M Friedman; Curt D Furberg
Community hospitals in clinical trials.
The New England journal of medicine 1982;307(15):958.
1982: Curt D Furberg; L Friedman; J Cutler
Should every survivor of a heart attack be given a beta-blocker?
British medical journal (Clinical research ed.) 1982;285(6343):738-9.
1982: W T Friedewald; Curt D Furberg
Clinical trials.
Circulation 1982;65(1):213-5.
1982: Curt D Furberg
The beta-blocker heart attack trial.
British journal of clinical pharmacology 1982;14 Suppl 1():3S-5S.
1982: G S May; K A Eberlein; Curt D Furberg; E R Passamani; D L DeMets
Secondary prevention after myocardial infarction: a review of long-term trials.
Progress in cardiovascular diseases 1982;24(4):331-52.
1981: G S May; D L DeMets; L M Friedman; Curt D Furberg; E Passamani
The randomized clinical trial: bias in analysis.
Circulation 1981;64(4):669-73.
1981: Curt D Furberg
[Hypertension in the aged].
Kätilölehti 1981;86(6):202-6.
1980: Curt D Furberg; G S May
Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
Circulation 1980;62(6 Pt 2):V49-52.
1980: L Friedman; E Passamani; G May; Curt D Furberg; W Friedewald
Placebo controlled double blind trials.
Lancet 1980;2(8186):147-8.
1980: D DeMets; L Friedman; Curt D Furberg
Counting events in clinical trials.
The New England journal of medicine 1980;302(16):924-5.
1980: P M Rautaharju; R J Prineas; R S Crow; D Seale; Curt D Furberg
The effect of modified limb electrode positions on electrocardiographic wave amplitudes.
Journal of electrocardiology 1980;13(2):109-13.
1980: Curt D Furberg
Principles of clinical trials: US viewpoint.
Triangle; the Sandoz journal of medical science 1980;19(3-4):99-102.
1977: Curt D Furberg; M Romo; E Linko; P Siltanen; G Tibblin; L Wilhelmsen
Sudden coronary death in Scandinavia. A report from Scandinavian coronary heart disease registers.
Acta medica Scandinavica 1977;201(6):553-7.
1975: Curt D Furberg; G Heinrich; J Hällén; H Hörnell; B W Johansson; B Jorming; L Malmberg; G Voigt
[The long QT-syndrome].
Läkartidningen 1975;72(47):4620-5.
1975: Curt D Furberg; H Hörnell
Familial qt prolongation and risk of sudden death.
Acta paediatrica Scandinavica 1975;64(5):777-82.
1975: Curt D Furberg
[Stopping smoking prolongs life].
Läkartidningen 1975;72(30-31):2936-8.
1975: J Boberg; M Boberg; Curt D Furberg; S O Isacsson
["Lipid research clinics"--a new concept in clinical atherosclerosis research].
Läkartidningen 1975;72(23):2517-21.
1975: S Zetterquist; Curt D Furberg; I Ringqvist; B Söderholm
Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
Current therapeutic research, clinical and experimental 1975;17(2):139-48.
1974: L Adolfsson; N H Areskog; Curt D Furberg; G Johnsson
Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
European journal of clinical pharmacology 1974;7(2):111-8.
1974: Curt D Furberg
Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.
Drugs 1974;7(1):106-17.
1973: Curt D Furberg; I Ringqvist
Achilles reflex time and sympathetic tone.
Upsala journal of medical sciences 1973;78(2):89-92.
1973: G Dahlen; C Ericson; Curt D Furberg
Study on pre-beta1 lipoprotein fraction.
Annales de biologie clinique 1973;31(2):115-7.
1972: Curt D Furberg; L Lundkvist; K Svärdsudd
[Preventive cardiology in Norrbotten].
Läkartidningen 1972;69(2):143-6.
1972: Curt D Furberg; L Lundkvist; K Svärdsudd
Preventive health program in Norrbotten with special reference to heart diseases.
Acta socio-medica Scandinavica. Supplement 1972;Suppl 6():200-2.
1972: G Dahlén; C Ericson; Curt D Furberg; L Lundkvist; K Svärdsudd
Studies on an extra pre-beta lipoprotein fraction.
Acta medica Scandinavica. Supplementum 1972;531():1-29.
1969: Curt D Furberg; G Michaelson
Effect of aptin, a beta-adrenergic blocking agent, in arterial hypertension.
Acta medica Scandinavica 1969;186(5):447-50.
1969: Curt D Furberg; H Linderholm
Effects of hyperventilation on ECG in patients with circulatory disturbances.
Acta medica Scandinavica 1969;185(3):167-74.
1968: Curt D Furberg; G von Schmalensee
Beta-adrenergic blockade and central circulation during exercise in sitting position in healthy subjects.
Acta physiologica Scandinavica 1968;73(4):435-46.
1968: Curt D Furberg
Effects of repeated work tests and adrenergic beta-blockade on electrocardiographic ST and T changes.
Acta medica Scandinavica 1968;183(1-2):153-61.
1968: Curt D Furberg
Effects of beta-adrenergic blockade on ECG, physical working capacity and central circulation with special reference to autonomic imbalance.
Acta medica Scandinavica. Supplementum 1968;488():7-46.
1967: Curt D Furberg
Adrenergic beta-blockade and physical working capacity.
Acta medica Scandinavica 1967;182(1):119-27.
1967: Curt D Furberg; T Ringquist
Penicillin and working capacity.
Lancet 1967;1(7490):622.
1967: F Bergman; Curt D Furberg
Adrenergic beta-receptor blockade and ECG changes of organic origin.
Scandinavian journal of clinical and laboratory investigation 1967;19(3):274-9.
1967: Curt D Furberg
Adrenergic beta-blockade and electrocardiographical ST-T changes.
Acta medica Scandinavica 1967;181(1):21-32.
1967: O Arvedson; Curt D Furberg; H Linderholm
The effect of a ganglionic blocking agent (chlorisondamine) on electrocardiogram, physical working capacity and hemodynamics in patients with vasoregulatory asthenia.
Acta medica Scandinavica. Supplementum 1967;472():36-53.
1967: Curt D Furberg; K A Jacobsson
Propranolol and angina pectoris. An analysis of the different responses to the drug in patients with angina pectoris.
Acta medica Scandinavica 1967;181(6):729-36.
1966: Curt D Furberg
[Value of exercise tests in coronary disease. (5). Beta-receptor adrenergic block in ECG diagnosis in connection with exercise tests].
Läkartidningen 1966;63(36):3349-54.
1966: Curt D Furberg
Adrenergic beta-receptor blockade and anaerobic metabolism.
Nature 1966;211(5051):888.
1966: Curt D Furberg; G Koch; H Ostlund
[The effect of a ganglionic-blocking substance on the orthostatic reaction and physical working capacity in lying and sitting positions in normal subjects].
Ärztliche Forschung 1966;20(6):305-7.
1966: Curt D Furberg; C F Tengblad
Adrenergic beta-receptor blockade and the effect of hyperventilation on the electrocardiogram.
Scandinavian journal of clinical and laboratory investigation 1966;18(5):467-72.
1964: D HOLMLUND; Curt D Furberg
[RESEARCH ON THE EFFECT OF PAPAVERINE ON THE OBSTRUCTED URETER].
Zeitschrift für Urologie 1964;57():633-7.
1963: Curt D Furberg; T RINGQVIST
[EFFECT OF PENICILLIN ON THE PHYSICAL CAPACITY FOR WORK AND ON THE EXPERIENCE OF FATIGUE DURING WORK].
Svenska läkartidningen 1963;60():2650-5.